Sleeve Gastrectomy in the Elderly.


Journal

Obesity facts
ISSN: 1662-4033
Titre abrégé: Obes Facts
Pays: Switzerland
ID NLM: 101469429

Informations de publication

Date de publication:
2019
Historique:
received: 28 06 2019
accepted: 12 08 2019
pubmed: 15 10 2019
medline: 12 2 2020
entrez: 15 10 2019
Statut: ppublish

Résumé

Even though risks are higher and long-term results may be less favorable, the elderly obese can still benefit from bariatric surgery. Whether the higher surgical risk is worth the benefits is yet to be determined. We reviewed our database and identified all patients aged 65 or older who underwent sleeve gastrectomy between May 2010 and November 2015. We documented patient demographics, obesity-related comorbidities, body mass index (BMI) before and after the procedure, percent excess weight loss, comorbidity improvement or resolution, length of follow-up, postoperative complications, re-operations, and length of hospital stay. We compared our study group to a control group of sleeve gastrectomy patients under the age of 65. Sixty-six patients (mean age 67.6 ± 2.6 years) underwent laparoscopic sleeve gastrectomy. Patients achieved an average of 53.5% excess BMI loss (EBMIL) after 21 months of follow-up. EBMIL was inferior to that achieved by the control group (EBMIL 77.3%, p < 0.0001). Elderly patients showed significant improvement or resolution in all obesity-related comorbidities. Complication and re-operation rates were similar between the 2 groups. In an elderly population, laparoscopic sleeve gastrectomy is safe and effective, yet weight loss outcomes are more modest when compared to a younger surgical population. Carefully selected elderly patients can benefit from bariatric surgery.

Sections du résumé

BACKGROUND
Even though risks are higher and long-term results may be less favorable, the elderly obese can still benefit from bariatric surgery. Whether the higher surgical risk is worth the benefits is yet to be determined.
MATERIALS AND METHODS
We reviewed our database and identified all patients aged 65 or older who underwent sleeve gastrectomy between May 2010 and November 2015. We documented patient demographics, obesity-related comorbidities, body mass index (BMI) before and after the procedure, percent excess weight loss, comorbidity improvement or resolution, length of follow-up, postoperative complications, re-operations, and length of hospital stay. We compared our study group to a control group of sleeve gastrectomy patients under the age of 65.
RESULTS
Sixty-six patients (mean age 67.6 ± 2.6 years) underwent laparoscopic sleeve gastrectomy. Patients achieved an average of 53.5% excess BMI loss (EBMIL) after 21 months of follow-up. EBMIL was inferior to that achieved by the control group (EBMIL 77.3%, p < 0.0001). Elderly patients showed significant improvement or resolution in all obesity-related comorbidities. Complication and re-operation rates were similar between the 2 groups.
CONCLUSION
In an elderly population, laparoscopic sleeve gastrectomy is safe and effective, yet weight loss outcomes are more modest when compared to a younger surgical population. Carefully selected elderly patients can benefit from bariatric surgery.

Identifiants

pubmed: 31610540
pii: 000502697
doi: 10.1159/000502697
pmc: PMC6876611
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

502-508

Informations de copyright

© 2019 The Author(s) Published by S. Karger AG, Basel.

Références

Surg Obes Relat Dis. 2007 Mar-Apr;3(2):163-9; discussion 169-70
pubmed: 17331804
Am J Physiol. 1997 Jul;273(1 Pt 1):E149-55
pubmed: 9252491
Surg Obes Relat Dis. 2009 Jul-Aug;5(4):469-75
pubmed: 19632646
Obes Surg. 2011 Aug;21(8):1180-7
pubmed: 21625908
Ann Surg. 2002 Nov;236(5):576-82
pubmed: 12409663
Obes Surg. 2006 Apr;16(4):461-4
pubmed: 16608611
J Gastrointest Surg. 2012 Jan;16(1):35-44; discussion 44
pubmed: 22038414
Obes Surg. 2016 Dec;26(12):3023-3030
pubmed: 27714526
Ann Intern Med. 2003 Jan 7;138(1):24-32
pubmed: 12513041
Surg Obes Relat Dis. 2015 Mar-Apr;11(2):296-301
pubmed: 25088486
Ann Surg. 2011 Oct;254(4):633-40
pubmed: 21897200
Curr Obes Rep. 2016 Jun;5(2):251-61
pubmed: 27115879
JAMA. 2010 Jan 20;303(3):235-41
pubmed: 20071471
Surg Obes Relat Dis. 2005 Jul-Aug;1(4):389-92; discussion 392-3
pubmed: 16925254
Arch Surg. 2007 Jun;142(6):506-10; discussion 510-2
pubmed: 17576885
Eur J Clin Nutr. 2000 Jun;54 Suppl 3:S121-5
pubmed: 11041083
BMJ. 2013 Oct 22;347:f5934
pubmed: 24149519
Obesity (Silver Spring). 2008 Feb;16(2):334-8
pubmed: 18239641
JAMA. 2005 Oct 19;294(15):1903-8
pubmed: 16234496
Ann Surg. 2012 Nov;256(5):724-8; discussion 728-9
pubmed: 23095615
Obes Surg. 2006 Dec;16(12):1579-83
pubmed: 17217633
JAMA. 2004 Oct 13;292(14):1724-37
pubmed: 15479938
Ageing Res Rev. 2010 Jan;9(1):1-11
pubmed: 19698803
N Engl J Med. 2009 Jul 30;361(5):445-54
pubmed: 19641201
Surg Endosc. 2013 Jun;27(6):2014-9
pubmed: 23344504
Surg Gynecol Obstet. 1977 Feb;144(2):192-4
pubmed: 835056
Arch Surg. 2006 Nov;141(11):1115-20; discussion 1121
pubmed: 17116805
Ann Surg. 2011 Sep;254(3):410-20; discussion 420-2
pubmed: 21865942

Auteurs

Nadav Nevo (N)

General Surgery Division, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty, Tel-Aviv-Yafo, Israel, dr.nevonadav@gmail.com.

Shai Meron Eldar (SM)

General Surgery Division, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty, Tel-Aviv-Yafo, Israel.
Bariatric Surgery Unit, The Tel-Aviv Sourasky Medical Center of Medicine, Tel Aviv University, Tel-Aviv-Yafo, Israel.

Yonatan Lessing (Y)

General Surgery Division, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty, Tel-Aviv-Yafo, Israel.

Edmond Sabo (E)

Department of Pathology, Technion, Haifa, Israel.

Ido Nachmany (I)

General Surgery Division, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty, Tel-Aviv-Yafo, Israel.

David Hazzan (D)

General Surgery Department C, Sheba Medical Center, Ramat Gan, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH